It's great to see our purpose-driven company receiving recognition for the role we play in global health. Check out the full list here: https://t.co/V0NRFnpszd #PFEColleague https://t.co/2TtQ020MsL
.@Pfizer has ramped up production of our #COVID19 vaccine & can deliver 10% more doses to the US by the end of May than previously agreed (total of 220M) & supply the full 300M agreed on for the end of July two weeks early. In the fight against COVID-19, we’re in this together.
#PfizerProud to have @POTUS stop by our Kalamazoo, Michigan site and recognize our essential manufacturing & supply chain colleagues who have been working tirelessly on #Covid19 vaccine production & shipping.🇺🇸 cc:@WHCovidResponse
📸: The first shipment from our Kalamazoo plant. @UPS@FedEx
.
.
The Pfizer-BioNTech #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use: https://t.co/OS1tgYopUj
NEWS: The Pfizer-@BioNTech_Group#COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 & older. See conditions of use: https://t.co/RbC0OwSEEi
248 long days and nights
150 active clinical trial sites
43,661 courageous volunteers
Thousands of dedicated @Pfizer and @BioNTech_Group colleagues
And the hopes of billions
All leading to 1 historic moment
#PfizerProud of our FDA Submission today: https://t.co/uyo6XfGSOO
Just as important as developing a safe, effective #COVID19 vaccine is getting it in the hands of people around the world. Today’s finalized supply agreement with the @EU_Commission is another major step toward that goal. #ScienceWillWin https://t.co/nvdtYbwhjJ
Today is a great day for both science and humanity, as the first set of results from our Phase 3 COVID-19 vaccine trial provides compelling evidence of our vaccine’s ability to help prevent COVID-19.
I have been explicit with my team, our leaders and all colleagues that, while our goal to deliver a vaccine is bold and ambitious – because that is what patients and our world need – under no circumstance is this to come at the expense of quality, safety or integrity.
We’re committed to helping governments have access to breakthroughs. Today we announced an agreement w/ Japan to supply, subject to regulatory approval, 120M doses of the mRNA-based COVID-19 vaccine candidate being co-developed by @Pfizer & @BioNTech_Group https://t.co/PmZEsrCRgZ
Today we took a step in our battle against #COVID19. After review of data from Phase 1/2 trials, @Pfizer and @BioNTech_Group have advanced our BNT162b2 vaccine candidate into a Phase 2/3 study. BNT162b2 recently received US FDA Fast Track designation. https://t.co/q0TwntzqcR
Since reopening, almost half the states have seen an increase in COVID cases.
That hasn’t happened in New York.
Let’s keep it that way.
The pandemic isn’t over and we MUST keep being vigilant.
Landmarks across the state are lit blue tonight in support of all the healthcare workers and all the essential personnel on the frontlines in our battle against #COVID19.
We thank them from the bottom of our hearts for all they do.
They are heroes. #LightItBlue#NewYorkTough
We have a tough fight ahead. New York City needs a staggering amount of equipment and personnel to meet this crisis and save every life we can.
15,000 more ventilators
45,000 more medical personnel
65,000 more hospital beds
We believe we can do it — IF we get the help we need.